- Adult RSV Has Significant Mortality, Morbidity That Is Comparable to Influenza A
- Risk Factors Identified for Reintubation for ARDS Secondary to COVID-19
- Critical Outcomes in COVID-19 Hospitalizations Decreased Over Time
- FDA Must Crack Down on Retailers Selling Tobacco to Teens: Report
- FDA Denies Approval of Intranasal Epinephrine, Requests Additional Study
- Do Infections or Autoimmune Diseases Better Predict Dementia Risk?
- Pneumocystis jiroveci Pneumonia Prophylaxis Associated With Adverse Events in AAV
- Metabolic Syndrome Linked to Risk for Lung Cancer, Especially in Women
- Short-Term Re-Exacerbation of COPD Predicts Long-Term Disease Prognosis
- Fluticasone Furoate Does Not Cut Time to COVID-19 Symptom Resolution
- FDA Wants More Data on First Needle-Free Antidote for Severe Allergic Reactions
- OSE2101 Vaccine Outperforms Standard Care in Certain Patients With NSCLC
Clinical Tools
Powered by
Powered by 
Blood Pressure-Lowering Medications Reduce Episodic Migraine Frequency
Long COVID May Affect More Patients Than Previously Thought
Elevated Triglyceride-Glucose Index Tied to Arthritis Development
Relationship Between New-Onset IRDs and COVID-19 Vaccination and Infection
Long COVID Symptoms Persist Through 12 Months
